Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
In the Phase 2 obesity trial published in the New England Journal of Medicine, the highest arm reached 24.2 percent average body weight loss at 48 weeks, and the curve had not flattened by the end
Keep reading to find out if BCBS will cover Wegovy, the drug coverage prior authorization criteria, and alternative options if you cant get coverage
10.1371/journal.pone.0053096 166 TsengC
In food-induced glucose-intolerant and prediabetic cynomolgus monkeys, oral administration of RGT-075 improved glucose tolerance and reduced food intake and fasting glucose levels
US$ 28.12
US$ 26.64
US$ 28.99
US$ 21.64
US$ 26.15
